| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.07B | $5.68B | $5.27B |
| YoY Revenue Growth % | +6.9% | +7.9% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.10B | $1.04B | $933.6M |
| Operating Margin % | 18.0% | 18.3% | 17.7% |
| Net Income (GAAP) | $660.3M | $604.1M | $545.3M |
| EBITDA (Normalized) | $1.31B | $1.25B | $1.12B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.62B | $1.32B | $1.12B |
| Capital Expenditures (CapEx) | $273.4M | $255.6M | $236.9M |
| Free Cash Flow (FCF) | $1.34B | $1.07B | $879.9M |
| FCF Margin % | 22.1% | 18.8% | 16.7% |
| Return on Invested Capital (ROIC %) | 10.2% | 9.2% | 10.6% |
| Cash & Short-Term Equivalents | $180.8M | $169.9M | — |
| Total Debt (Short + Long Term) | $4.06B | $4.32B | $2.70B |
| Total Stockholders' Equity | $4.60B | $4.80B | $5.54B |